CV Sciences (CVSI) Operating Income (2012 - 2026)
CV Sciences' (CVSI) quarterly Operating Income came in at -$318000.0 in Q1 2026, down 2990.91% year-on-year from $11000.0 in Q1 2025, and down 262.24% quarter-over-quarter from $196000.0 in Q4 2025.
CV Sciences (CVSI) Operating Income (2012 - 2026) Analysis & Trends
CV Sciences has disclosed Operating Income across 15 years of filings, most recently posting -$318000.0 for Q1 2026.
- Operating Income for Q1 2026 came in at -$318000.0, down 2990.91% year-over-year; the trailing twelve-month figure through Mar 2026 was -$528000.0 (up 66.13% YoY), and the FY2025 annual result was -$199000.0, up 90.91% from the prior year.
- Operating Income came in at -$318000.0 for Q1 2026 at CV Sciences, down from $196000.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $5.8 million in Q1 2023 to a low of -$2.3 million in Q2 2022.
- The 5-year median for Operating Income is -$583000.0 (2024), against an average of -$364352.9.
- Across the five-year window, Operating Income jumped 480.33% in 2023 and sank 2990.91% in 2026, its largest moves.
- CV Sciences' Operating Income stood at -$2.1 million in 2022, then jumped by 58.16% to -$889000.0 in 2023, then rose by 27.33% to -$646000.0 in 2024, then surged by 130.34% to $196000.0 in 2025, then sank by 262.24% to -$318000.0 in 2026.
- The last three Operating Income figures came in at -$318000.0 (Q1 2026), $196000.0 (Q4 2025), and -$275000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 14.03 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 193.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -48.28 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -78.32 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 81.33 Mn |
| 10 | CV Sciences | - | - | 1.56 Mn | -318,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -318,000.00 |
| Dec 31, 2025 | 196,000.00 |
| Sep 30, 2025 | -275,000.00 |
| Jun 30, 2025 | -131,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | -646,000.00 |
| Sep 30, 2024 | -341,000.00 |
| Jun 30, 2024 | -583,000.00 |
| Mar 31, 2024 | -620,000.00 |
| Dec 31, 2023 | -889,000.00 |
| Sep 30, 2023 | -437,000.00 |
| Jun 30, 2023 | -1.08 Mn |
| Mar 31, 2023 | 5.76 Mn |
| Dec 31, 2022 | -2.13 Mn |
| Sep 30, 2022 | -892,000.00 |
| Jun 30, 2022 | -2.32 Mn |
| Mar 31, 2022 | -1.52 Mn |
| Dec 31, 2021 | -8.84 Mn |
| Sep 30, 2021 | -2.98 Mn |
| Jun 30, 2021 | -3.51 Mn |